Advancements in AI, multi-omics, and genome editing are transforming life sciences and biotechnology, addressing new ...

Explore the role of transcription factor biology in drug discovery and how it impacts our understanding of disease mechanisms ...

A research team has uncovered key molecular insights into how the hybrid rice variety Liangyou 287 (LY287) achieves superior ...

The Global Cancer Biomarkers Market is projected to grow at a CAGR of 8.6% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that the market was ...

Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

Plants rely on complex chemical defenses to survive attacks from pathogens, yet the genetic basis underlying the production ...

The U.S. next generation sequencing market size was valued at USD 2.85 billion in 2025 and is predicted to hit around USD 12.52 billion by 2035, rising at a 15.95% CAGR, a study published by Towards ...

Illumina is building the most comprehensive multiomic solutions in the industry, anchored on its world-class sequencing platforms for unmatched quality and scale. For research and pharma innovators, ...

This year, hype around AI really exploded, and so did concerns about AI’s environmental footprint. We also saw some surprising biotech developments. It's been a busy and productive year here at MIT ...